Biomarker analysis of phase (Ph) IB trial of radium-223 (Rad) and niraparib (Nira) in patients (Pts) with metastatic castrate-resistant prostate cancer (mCRPC) (NiraRad).

被引：1
|
作者：
Yang, Eddy Shih-Hsin
Leiby, Benjamin
Sonpavde, Guru P.
Einstein, David Johnson
Quinn, Zachary L.
Szmulewitz, Russell Zelig
Sartor, A. Oliver
Kelly, William Kevin
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA
[3] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[5] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[6] Univ Chicago, Chicago, IL 60637 USA
[7] Tulane Canc Ctr, New Orleans, LA USA
[8] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.5036
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5036
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Radium-223 (Rad) and niraparib (Nira) treatment (tx) in castrate-resistant prostate cancer (CRPC) patients (pts) with and without prior chemotherapy (chemo).
    Kelly, William Kevin
    Leiby, Benjamin
    Einstein, David Johnson
    Szmulewitz, Russell Zelig
    Sartor, A. Oliver
    Yang, Eddy Shih-Hsin
    Sonpavde, Guru
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] A phase Ib trial to study the safety and tolerability of atezolizumab with radium-223 dichloride in patients with metastatic castrate-resistant prostate cancer (mCRPC)
    Fong, Lawrence
    Morris, Michael
    Armstrong, Andrew
    Petrylak, Daniel
    Vaishampayan, Ulka
    Alva, Ajjai
    Hoffman-Censits, Jean
    Sarkar, Indrani
    Carroll, Susheela
    Schiff, Christina
    Sartor, Oliver
    [J]. CANCER RESEARCH, 2017, 77
  • [3] Radium-223 for Metastatic Castrate-Resistant Prostate Cancer
    Sindhu, Kunal K.
    Nehlsen, Anthony D.
    Stock, Richard G.
    [J]. PRACTICAL RADIATION ONCOLOGY, 2022, 12 (04) : 312 - 316
  • [4] c15-162: Phase IB trial of radium 223 and niraparib in patients with castrate resistant prostate cancer (NiraRad).
    Godwin, James Luke
    Hoffman-Censits, Jean H.
    Den, Robert Benjamin
    Knudsen, Karen E.
    Schiewer, Matthew Joseph
    Leiby, Benjamin E.
    Southwell, Traci
    Hubert, Christine
    Patnaik, Akash
    Sonpavde, Guru
    Sartor, A. Oliver
    Yang, Eddy Shih-Hsin
    Kelly, William Kevin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [5] Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer
    Quinn, Zachary
    Leiby, Benjamin
    Sonpavde, Guru
    Choudhury, Atish D.
    Sweeney, Christopher
    Einstein, David
    Szmulewitz, Russell
    Sartor, Oliver
    Knudsen, Karen
    Yang, Eddy Shih-Hsin
    Kelly, Wm. Kevin
    [J]. CLINICAL CANCER RESEARCH, 2023, 29 (01) : 50 - 59
  • [6] Radium-223 therapy for metastatic castrate-resistant prostate cancer
    Lehman, Ashley
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [7] Radium-223 therapy for metastatic castrate-resistant prostate cancer
    Lehman, Ashley
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [8] Radium-223 in Heavily Pretreated Metastatic Castrate-Resistant Prostate Cancer
    Modi, Dipenkumar
    Hwang, Clara
    Mamdani, Hirva
    Kim, Seongho
    Gayar, Hesham
    Vaishampayan, Ulka
    Joyrich, Richard
    Heath, Elisabeth I.
    [J]. CLINICAL GENITOURINARY CANCER, 2016, 14 (05) : 373 - 380
  • [9] Pain Response to Radium-223 in Men With Metastatic Castrate-Resistant Prostate Cancer
    Zhang, I.
    Gilbo, P.
    Cox, B. W.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E530 - E530
  • [10] Single-Institution Experience With Radium-223 Dichloride (Ra-223) for Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
    Cox, B. W.
    Wang, L.
    Bradley, T.
    Gu, B.
    Kelley, K.
    Potters, L.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S470 - S470
12345